Metabolomics and Genomics Enable the Discovery of a New Class of Nonribosomal Peptidic Metallophores from a Marine Micromonospora
- PMID: 36535031
- PMCID: PMC10570848
- DOI: 10.1021/jacs.2c06410
Metabolomics and Genomics Enable the Discovery of a New Class of Nonribosomal Peptidic Metallophores from a Marine Micromonospora
Abstract
Although microbial genomes harbor an abundance of biosynthetic gene clusters, there remain substantial technological gaps that impair the direct correlation of newly discovered gene clusters and their corresponding secondary metabolite products. As an example of one approach designed to minimize or bridge such gaps, we employed hierarchical clustering analysis and principal component analysis (hcapca, whose sole input is MS data) to prioritize 109 marine Micromonospora strains and ultimately identify novel strain WMMB482 as a candidate for in-depth "metabologenomics" analysis following its prioritization. Highlighting the power of current MS-based technologies, not only did hcapca enable the discovery of one new, nonribosomal peptide bearing an incredible diversity of unique functional groups, but metabolomics for WMMB482 unveiled 16 additional congeners via the application of Global Natural Product Social molecular networking (GNPS), herein named ecteinamines A-Q (1-17). The ecteinamines possess an unprecedented skeleton housing a host of uncommon functionalities including a menaquinone pathway-derived 2-naphthoate moiety, 4-methyloxazoline, the first example of a naturally occurring Ψ[CH2NH] "reduced amide", a methylsulfinyl moiety, and a d-cysteinyl residue that appears to derive from a unique noncanonical epimerase domain. Extensive in silico analysis of the ecteinamine (ect) biosynthetic gene cluster and stable isotope-feeding experiments helped illuminate the novel enzymology driving ecteinamine assembly as well the role of cluster collaborations or "duets" in producing such structurally complex agents. Finally, ecteinamines were found to bind nickel, cobalt, zinc, and copper, suggesting a possible biological role as broad-spectrum metallophores.
Conflict of interest statement
The authors declare no competing financial interest.
Figures








References
-
- Wolfender JL; Litaudon M; Touboul D; Queiroz EF Innovative omics-based approaches for prioritisation and targeted isolation of natural products - new strategies for drug discovery. Nat. Prod. Rep 2019, 36, 855–868. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P41 RR002301/RR/NCRR NIH HHS/United States
- U19 AI109673/AI/NIAID NIH HHS/United States
- S10 RR029220/RR/NCRR NIH HHS/United States
- U19 AI142720/AI/NIAID NIH HHS/United States
- P41 GM136463/GM/NIGMS NIH HHS/United States
- R01 AT009874/AT/NCCIH NIH HHS/United States
- S10 RR025062/RR/NCRR NIH HHS/United States
- R24 GM141526/GM/NIGMS NIH HHS/United States
- S10 RR002781/RR/NCRR NIH HHS/United States
- P41 GM103399/GM/NIGMS NIH HHS/United States
- S10 RR008438/RR/NCRR NIH HHS/United States
- S10 RR023438/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources